Page Bouchard
- Immunology top 5%
- Immune Cell Function and Interaction 7
- Biosimilars and Bioanalytical Methods 3
- IL-33, ST2, and ILC Pathways 2
- Immune Response and Inflammation 2
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 3
- Immunology and Allergy top 10%
-
- Inflammasome and immune disorders 3
- Pharmacology top 10%
-
- Computational Drug Discovery Methods 2
-
- Statistical Methods in Clinical Trials 2
- Co-authors
- Kristin ThompsonRenta HutabaratWilliam E. CarsonJonathan LamD. HolbertW. James MetzgerSanjiv SurMichael A. Caligiuri
- Partner nations
- United StatesSwitzerlandCanada
In The Last Decade
Page Bouchard
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 116
- Immunology 511
- Oncology 283
- Immunology and Allergy 60
- Molecular Biology 438
- Pharmacology 51
Countries citing papers authored by Page Bouchard
This map shows the geographic impact of Page Bouchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Page Bouchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Page Bouchard more than expected).
Fields of papers citing papers by Page Bouchard
This network shows the impact of papers produced by Page Bouchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Page Bouchard. The network helps show where Page Bouchard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Page Bouchard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2018 | 3 | |
| 3 | 2018 | 1 | |
| 4 | 2012 | 13 | |
| 5 | 2010 | 257 | |
| 6 | 2008 | 44 | |
| 7 | 2004 | 13 | |
| 8 | [Pilot study and preliminary validation of the French version of a quality-of-life questionnaire specific for subjects with growth hormone deficiency]. | 2003 | 3 |
| 9 | 2002 | 11 | |
| 10 | 2002 | 18 | |
| 11 | 2001 | 34 | |
| 12 | 2000 | 5 | |
| 13 | 2000 | 89 | |
| 14 | 1999 | 60 | |
| 15 | 1999 | 91 | |
| 16 | 1998 | 255 | |
| 17 | Preclinical studies of recombinant factor IX. | 1998 | 5 |
| 18 | 1996 | 13 | |
| 19 | 1996 | 122 | |
| 20 | 1989 | 35 |
About Page Bouchard
Page Bouchard is a scholar working on Immunology, Statistics and Probability, Hematology, Oncology and Emergency Medical Services, having authored 22 papers that have together received 1.1k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Inflammasome and immune disorders (3 papers), Biosimilars and Bioanalytical Methods (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Computational Drug Discovery Methods (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Immune Response and Inflammation (2 papers) and Statistical Methods in Clinical Trials (2 papers). The work is most often cited by research in Immunology (511 citations), Oncology (283 citations), Immunology and Allergy (60 citations), Molecular Biology (438 citations) and Pharmacology (51 citations). Page Bouchard has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include Kristin Thompson, Renta Hutabarat, William E. Carson, Jonathan Lam, D. Holbert, W. James Metzger, Sanjiv Sur, Michael A. Caligiuri, Julie Dierksheide and Carol Becker Lynch. Their work appears in journals such as Blood, The Journal of Immunology, The Pharmacogenomics Journal, Journal of Biomedical Materials Research and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.